Non-invasive electromagnetic waves can rebalance immune cytokines, reduce chronic inflammation, and was associated with sustained cognitive benefit in Alzheimer’s patients, suggesting broader potential for promoting healthy aging.

This recent review highlights the potential of photobiomodulation in mitigating symptoms and progression in neurodegenerative diseases like Alzheimer’s and Parkinson’s, synthesizing evidence from animal and clinical studies.

This review discusses the role of gamma oscillations in regulating brain plasticity, neuroinflammation, and amyloid processing, advocating gamma entrainment as a promising non-invasive neuromodulation tool.

Advancements in wearable brain-stimulation devices offer promising non-invasive treatments for neurodegenerative diseases.

Red and near-infrared light therapy enhances cerebral blood flow and may slow cognitive decline.

Recent research shows that gamma wave stimulation can reduce amyloid plaques and improve memory in Alzheimer's patients.

Radiofrequency waves does not increase brain temperature even at high power levels. These results support the safety for radiofrequency treatment for long term daily treatment targeting cognitive decline in Alzheimer's disease.

A wearable system using customized rTMS showed a statistically significant slowdown in Alzheimer's progression after a 12-month trial.

This clinical trial introduces a wearable headband that applies mild electric fields to potentially improve brain function in mild-to-moderate Alzheimer’s patients.